RPS15AP24

Across TCGA pan-cancer cohorts, RPS15AP24 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RPS15AP24’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS15AP24 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS15AP24 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

KIRC, COAD, and CHOL are the cancer types where RPS15AP24 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS15AP24 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	III,IV	+0.750	<.001	11	view →
COAD	Female	II,III,IV	+1.544	<.001	9	view →
CHOL	All	All	+0.557	<.001	5	view →
LIHC	All	II,III,IV	+0.177	.002	4	view →
READ	All	II,III,IV	+0.937	.021	2	view →
PRAD	All	All	+0.256	.005	2	view →
KIRP	Male	All	+0.173	.027	2	view →
LUSC	All	All	−0.165	.022	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

RPS15AP24–KIRC

Open the KIRC breakdown →